FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511133632> ?p ?o ?g. }

• W2511133632 abstract "Abstract Blockade of the epidermal growth factor receptor (EGFR) by EGFR tyrosine kinase inhibitors is insufficient for effective anti-tumor activity because the reactivation of the ErbB3 signaling pathway significantly contributes to activating the consequent phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. Combinatorial therapies including ErbB3 targeting may ameliorate tumor responses to anti-EGFR therapies. In the present study, we found that in BxPC-3 and L3.6pl cells, which highly expressed the ErbB3 receptor, significant reduction in cell viability, induction of apoptosis were observed when treated with a combination of erlotinib and PF compared to either agent alone. Moreover, in ErbB3-expressing BxPC-3, L3.6pl and S 2 VP 10 cell lines, the inhibition of ErbB3/PI3K/Akt phosphorylation were observed when treated with PF. Most strikingly, both EGFR/MAPK/Erk and ErbB3/PI3K/Akt activitions were substantially suppressed when treated with the combination of PF and erlotinib. However, in the ErbB3-deficient cell line MIAPaCa-2, no such effects were observed with similar treatments. Most importantly, these in vitro results were replicated in nude mouse transplanted tumor models. Taken together, our findings show that PF enhances the effect of erlotinib in ErbB3-expressing pancreatic cancer cells by directly suppressing ErbB3 activation, and PF in combination with erlotinib is much more effective as an antitumor agent compared with either agent alone." @default.
• W2511133632 created "2016-09-16" @default.
• W2511133632 creator A5000111816 @default.
• W2511133632 creator A5020177316 @default.
• W2511133632 creator A5038493361 @default.
• W2511133632 creator A5045391521 @default.
• W2511133632 creator A5055436613 @default.
• W2511133632 creator A5057273967 @default.
• W2511133632 creator A5058225466 @default.
• W2511133632 creator A5068805735 @default.
• W2511133632 date "2016-09-09" @default.
• W2511133632 modified "2023-10-16" @default.
• W2511133632 title "Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation" @default.
• W2511133632 cites W136642420 @default.
• W2511133632 cites W1539800843 @default.
• W2511133632 cites W1561050353 @default.
• W2511133632 cites W1889456003 @default.
• W2511133632 cites W1979479023 @default.
• W2511133632 cites W1993560013 @default.
• W2511133632 cites W1995080755 @default.
• W2511133632 cites W1998971866 @default.
• W2511133632 cites W2009843946 @default.
• W2511133632 cites W2013804962 @default.
• W2511133632 cites W2017081079 @default.
• W2511133632 cites W2021688157 @default.
• W2511133632 cites W2021786645 @default.
• W2511133632 cites W2027515445 @default.
• W2511133632 cites W2028938256 @default.
• W2511133632 cites W2031921149 @default.
• W2511133632 cites W2032132018 @default.
• W2511133632 cites W2037690883 @default.
• W2511133632 cites W2038199402 @default.
• W2511133632 cites W2055909810 @default.
• W2511133632 cites W2059960332 @default.
• W2511133632 cites W2065141010 @default.
• W2511133632 cites W2068944199 @default.
• W2511133632 cites W2070727232 @default.
• W2511133632 cites W2073251204 @default.
• W2511133632 cites W2076098855 @default.
• W2511133632 cites W2080872013 @default.
• W2511133632 cites W2087861588 @default.
• W2511133632 cites W2103063851 @default.
• W2511133632 cites W2108246579 @default.
• W2511133632 cites W2119073457 @default.
• W2511133632 cites W2135836172 @default.
• W2511133632 cites W2156214225 @default.
• W2511133632 cites W2158134441 @default.
• W2511133632 cites W2161338384 @default.
• W2511133632 cites W2165480504 @default.
• W2511133632 cites W2167157100 @default.
• W2511133632 cites W2169961966 @default.
• W2511133632 cites W2170432735 @default.
• W2511133632 cites W2219978888 @default.
• W2511133632 cites W2322421636 @default.
• W2511133632 cites W3144138202 @default.
• W2511133632 doi "https://doi.org/10.1038/srep32809" @default.
• W2511133632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5016851" @default.
• W2511133632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27609096" @default.
• W2511133632 hasPublicationYear "2016" @default.
• W2511133632 type Work @default.
• W2511133632 sameAs 2511133632 @default.
• W2511133632 citedByCount "19" @default.
• W2511133632 countsByYear W25111336322017 @default.
• W2511133632 countsByYear W25111336322018 @default.
• W2511133632 countsByYear W25111336322019 @default.
• W2511133632 countsByYear W25111336322020 @default.
• W2511133632 countsByYear W25111336322022 @default.
• W2511133632 countsByYear W25111336322023 @default.
• W2511133632 crossrefType "journal-article" @default.
• W2511133632 hasAuthorship W2511133632A5000111816 @default.
• W2511133632 hasAuthorship W2511133632A5020177316 @default.
• W2511133632 hasAuthorship W2511133632A5038493361 @default.
• W2511133632 hasAuthorship W2511133632A5045391521 @default.
• W2511133632 hasAuthorship W2511133632A5055436613 @default.
• W2511133632 hasAuthorship W2511133632A5057273967 @default.
• W2511133632 hasAuthorship W2511133632A5058225466 @default.
• W2511133632 hasAuthorship W2511133632A5068805735 @default.
• W2511133632 hasBestOaLocation W25111336321 @default.
• W2511133632 hasConcept C115456853 @default.
• W2511133632 hasConcept C121608353 @default.
• W2511133632 hasConcept C126322002 @default.
• W2511133632 hasConcept C170493617 @default.
• W2511133632 hasConcept C185592680 @default.
• W2511133632 hasConcept C2777506169 @default.
• W2511133632 hasConcept C2778087573 @default.
• W2511133632 hasConcept C2779251935 @default.
• W2511133632 hasConcept C2779438470 @default.
• W2511133632 hasConcept C2780210213 @default.
• W2511133632 hasConcept C502942594 @default.
• W2511133632 hasConcept C55493867 @default.
• W2511133632 hasConcept C57074206 @default.
• W2511133632 hasConcept C62478195 @default.
• W2511133632 hasConcept C71924100 @default.
• W2511133632 hasConcept C75217442 @default.
• W2511133632 hasConcept C86554907 @default.
• W2511133632 hasConcept C98274493 @default.
• W2511133632 hasConceptScore W2511133632C115456853 @default.
• W2511133632 hasConceptScore W2511133632C121608353 @default.
• W2511133632 hasConceptScore W2511133632C126322002 @default.
• W2511133632 hasConceptScore W2511133632C170493617 @default.

• next